#monkeypox

#monkeypox

The WHO declared a Public Health Emergency due to a deadly variant of mpox spreading rapidly in Africa.

The new mpox variant presents a unique and multi-faceted public health threat.

The situation is exacerbated by limited healthcare resources in affected African countries.

A new variant of the mpox virus is spreading rapidly in Central Africa, raising global health concerns.

Tecovirimat, approved in Europe for mpox, showed limited effectiveness in hastening recovery in human clinical trials.

Mpox, previously known as monkeypox, has resurfaced in South Africa with fatalities, causing alarm due to its transmission through close contact with infected individuals or materials.

Mpox infections in Africa have surged dramatically, prompting the WHO to declare a public health emergency of international concern.

The UK has detected two new cases of a more-infectious mpox strain, Clade 1b, primarily affecting close contacts of an initial case.

Dr. Jay Varma's comments suggest manipulative media tactics were utilized to gain FDA approval for a drug with questionable efficacy.

Tecovirimat does not accelerate healing in clade I monkeypox cases, raising concerns about treatment efficacy.

Mpox virus variants are increasing in Central Africa, requiring awareness and caution due to painful symptoms and limited treatment options.

Toronto Public Health urges vaccination against mpox as cases rise.

The number of monkeypox cases in the Big Apple spiked since October, primarily affecting Black/Hispanic men aged 25-44, with most cases being mild.

Monkeypox continues to circulate in NYC, especially among unvaccinated individuals, urging the importance of vaccination against the virus.